Structure of 'immortality protein' now better understood

September 10, 2020

A key role in studying the telomerase of Hansenula polymorpha was played by KFU's nuclear magnetic resonance spectrometer.

"The work frequency of our NMR spectrometer with a cryo sensor is 700 MHz. It can glance into the structure of the most complex biochemical objects and detect how they interact with cell membranes," shares Head of NMR Lab, Professor Vladimir Klochkov.

The telomerase was studied by the Department of Medical Physics (Kazan Federal University) and the Laboratory of Magnetic Spectroscopy and Tomography (Moscow State University).

"Telomerase, as many complex enzymes, is not just a protein molecule, but rather a combination of several subunits. A fragment of one of the subunits, the Est2 protein, was studied by us earlier, and now we studied the structure and functions of Est3," explains co-author, Senior Research Associate Sergey Efimov. "We found out that Est3 is important for the stabilization of the whole protein complex."

Spectroscopy helped understand the spatial structure of Est3 molecules and the interaction between them.

"When molecules interact, you can see a general picture through resonance frequencies and other spectral characteristics of magnetic nuclei in their structure - how proteins contact with each other and the DNA strand, which subunits are responsible for attaching the enzyme to the DNA, and which move the complex along the chain and restore telomeres," adds Efimov.

The analogs of the studied yeast proteins can be found in telomerases of higher organisms, including humans. If scientists create medications to influence particular components in the telomerase to suppress its activities in cancer cells, we will be able to counter the progress of oncological diseases.

"As an organism grows, telomeres become shorter. The purpose is to limit the further division of cells which might have amassed errors in their DNA. Such a limitation does not exist in embryonic and stem cells thanks to the telomerase. This enzyme restores telomeres at the ends of chromosomes. A similar process happens during malignant changes in cells. Telomeres and systems of length control exist in all eukaryotes," concludes Dr. Efimov.
-end-


Kazan Federal University

Related Cancer Cells Articles from Brightsurf:

Cancer researchers train white blood cells to attacks tumor cells
Scientists at the National Center for Tumor Diseases Dresden (NCT/UCC) and Dresden University Medicine, together with an international team of researchers, were able to demonstrate that certain white blood cells, so-called neutrophil granulocytes, can potentially - after completing a special training program -- be utilized for the treatment of tumors.

New way to target some rapidly dividing cancer cells, leaving healthy cells unharmed
Scientists at Johns Hopkins Medicine and the University of Oxford say they have found a new way to kill some multiplying human breast cancer cells by selectively attacking the core of their cell division machinery.

Breast cancer cells use message-carrying vesicles to send oncogenic stimuli to normal cells
According to a Wistar study, breast cancer cells starved for oxygen send out messages that induce oncogenic changes in surrounding normal epithelial cells.

Breast cancer cells turn killer immune cells into allies
Researchers at Johns Hopkins University School of Medicine have discovered that breast cancer cells can alter the function of immune cells known as Natural killer (NK) cells so that instead of killing the cancer cells, they facilitate their spread to other parts of the body.

Breast cancer cells can reprogram immune cells to assist in metastasis
Johns Hopkins Kimmel Cancer Center investigators report they have uncovered a new mechanism by which invasive breast cancer cells evade the immune system to metastasize, or spread, to other areas of the body.

Engineered immune cells recognize, attack human and mouse solid-tumor cancer cells
CAR-T therapy has been used successfully in patients with blood cancers such as lymphoma and leukemia.

Drug that keeps surface receptors on cancer cells makes them more visible to immune cells
A drug that is already clinically available for the treatment of nausea and psychosis, called prochlorperazine (PCZ), inhibits the internalization of receptors on the surface of tumor cells, thereby increasing the ability of anticancer antibodies to bind to the receptors and mount more effective immune responses.

Engineered bone marrow cells slow growth of prostate and pancreatic cancer cells
In experiments with mice, researchers at the Johns Hopkins Kimmel Cancer Center say they have slowed the growth of transplanted human prostate and pancreatic cancer cells by introducing bone marrow cells with a specific gene deletion to induce a novel immune response.

First phase i clinical trial of CRISPR-edited cells for cancer shows cells safe and durable
Following the first US test of CRISPR gene editing in patients with advanced cancer, researchers report these patients experienced no negative side effects and that the engineered T cells persisted in their bodies -- for months.

Zika virus' key into brain cells ID'd, leveraged to block infection and kill cancer cells
Two different UC San Diego research teams identified the same molecule -- αvβ5 integrin -- as Zika virus' key to brain cell entry.

Read More: Cancer Cells News and Cancer Cells Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.